Tesserent need results plain and simple. No excuses. Said it before and will say it again - if results don’t improve this FY heads should roll - strategy isn’t working.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025